An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
about
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseDocosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trialPerispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanismTNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot studyCurrent pharmacologic options for patients with Alzheimer's diseaseA practical algorithm for managing Alzheimer's disease: what, when, and why?Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysisDescribing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.Influence of age, circadian and homeostatic processes on inhibitory motor control: a Go/Nogo task studyTechnology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trialA multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's diseasePromotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairmentSertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.Detecting Change over Time: A Comparison of the SLUMS Examination and the MMSE in Older Adults at Risk for Cognitive DeclineMajor Depressive Symptoms Increase 3-Year Mortality Rate in Patients with Mild Dementia.MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study populationEffect of TTP488 in patients with mild to moderate Alzheimer's disease.Understanding the complexities of functional ability in Alzheimer's disease: more than just basic and instrumental factorsDevelopment of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging.A complex multimodal activity intervention to reduce the risk of dementia in mild cognitive impairment--ThinkingFit: pilot and feasibility study for a randomized controlled trial.Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease.Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes.Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver OutcomesReduced lean mass in early Alzheimer disease and its association with brain atrophy.Update on the pharmacological treatment of Alzheimer's diseaseMaintenance Cognitive Stimulation Therapy (CST) for dementia: a single-blind, multi-centre, randomized controlled trial of Maintenance CST vs. CST for dementia.Digitally translated Self-Administered Gerocognitive Examination (eSAGE): relationship with its validated paper version, neuropsychological evaluations, and clinical assessments.BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory studyDiscontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients.Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.Quality of life of residents with dementia in long-term care settings in the Netherlands and Belgium: design of a longitudinal comparative study in traditional nursing homes and small-scale living facilities.Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort.Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)
P2860
Q21146622-925D2117-1110-4F43-ABE0-ACC27B1093B4Q24607545-184181AD-FA1F-479A-B504-6C7AA983E0BCQ24652684-F606955E-EC08-47D8-9BD8-A066F79D107CQ24681139-BDF26749-C5F8-40FE-ADC5-29A24F35B8E2Q24800530-FF857597-CDEE-49A5-B0DC-E2D9A25C9EB5Q26859831-C635484C-60B8-47C0-845A-D6711E82BFAAQ26861399-5082A113-572B-44D4-993C-013DC19CCCE2Q27333816-6259E155-C92F-449D-BF19-DB8A6AB64028Q28385639-9482CA08-63C3-4937-BC5A-DEBD0963F86CQ28394889-0B021C59-1F62-4B5E-A037-1AAE5BB9F8D4Q30405370-DE9AE612-2352-443F-BEF5-0FDCA7F1534BQ30544056-E19A818D-F05B-49CD-BDFB-82795576F0CCQ30584897-7FD01ABE-763D-46D8-9248-AC892F8D413CQ30586321-78A9D159-BCAD-4F35-81E2-5D3240741F13Q30616078-24229270-1387-4DF0-BF03-BF5C311CA3F4Q30736054-BE0794B9-05DF-426B-99C0-5D11F270D57DQ33531561-5A778CC5-EA21-4766-9A45-E01BDFB6FE68Q33539531-535A1F1C-88AA-431B-B73F-6C13F81A3F5DQ33574870-E1324A1B-F60F-49DD-8478-E6D4ABD69E15Q33581786-A0395914-BF54-4CE8-8D73-9DCA28B0072DQ33584191-CF0BBBC1-28FC-4414-BD17-F1FEA7C7C5A9Q33611402-9770D483-4474-47DA-A944-A1AA32F019BCQ33613270-A3712B28-85E0-4872-ACB0-D0C899DD9D45Q33650931-0BB53DD3-6FFA-403F-8E97-B410099624D0Q33675522-8DED5FB4-9ACB-4214-926E-BFDCA20207C8Q33676115-C910C77F-8867-428C-A746-6C5272AB5CCEQ33682682-1E08B2E8-D4C9-4243-B880-9630D4E4EE81Q33696248-E4EAB56F-05D2-4F4C-AB04-AD6F7813E1D6Q33736797-8C50D5EC-6EF1-43D2-8550-F56DA2565A2EQ33781824-6C420865-537E-4651-80EF-CA498CCD6E40Q33791606-4F084DD1-B299-4D52-9599-C34AA6E3F3F4Q33836947-6EF251A7-6AD4-458A-8EEE-3E188DA3465DQ33843171-238F37B1-BB57-42EB-93AD-D33856AF0682Q33846639-7EC9FDC8-6F23-4C6D-ADAB-CF8912EF7E21Q33854887-24173203-6179-4FF6-94D5-6F6D27F79347Q33858264-9346D876-001D-4A23-8D8F-54B144CF87C8Q33863623-824492A8-37E3-4337-BC37-E76E4E44BE04Q33888693-18B01F9C-1751-4E00-8A7A-AAC175481AB3Q33891581-CB95EA47-E222-4B19-9D0D-18651F67783DQ33895643-98BF8992-9155-447B-AD65-220A1D60B926
P2860
An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
An inventory to assess activit ...... r's Disease Cooperative Study.
@ast
An inventory to assess activit ...... r's Disease Cooperative Study.
@en
An inventory to assess activit ...... r's Disease Cooperative Study.
@nl
type
label
An inventory to assess activit ...... r's Disease Cooperative Study.
@ast
An inventory to assess activit ...... r's Disease Cooperative Study.
@en
An inventory to assess activit ...... r's Disease Cooperative Study.
@nl
prefLabel
An inventory to assess activit ...... r's Disease Cooperative Study.
@ast
An inventory to assess activit ...... r's Disease Cooperative Study.
@en
An inventory to assess activit ...... r's Disease Cooperative Study.
@nl
P2093
P1476
An inventory to assess activit ...... er's Disease Cooperative Study
@en
P2093
P407
P478
11 Suppl 2
P577
1997-01-01T00:00:00Z